Clinical Study

Prevalence and Risk Factors of Sexually Transmitted Infections and Cervical Neoplasia in Women from a Rural Area of Southern Mozambique

Table 3

Significant variables according to the multivariate analysis of risk factors for STIs and cervical neoplasia.

InfectionVariableMultivariate OR*(95% CI) -value**

Gonococcal infectionNumber of sexual partners11.014
12.8(1.2; 6.2)

Syphilis (RPR & IgG)HPVNo1.005
Yes3.2(1.4; 7.5)

Syphilis (RPR & IgG)Marital statusNever married1.005
Married now0.7(0.1; 3.9)
Divorced or widowed3.6(0.6; 21.9)

HPVCervical neoplasiaNo1 .0001
Yes9.8(3.7; 26.3)
Unknown2.7(0.6; 12.0)

HPVRPRNo1 .0001
Yes4.1(1.9; 9.1)

HPVAnogenital wartsNo1.054
Yes4.2(1.0; 17.8)

HIVMarital statusNever married1.005
Married now0.5(0.1; 2.3)
Divorced or widowed2.7(0.5; 16.0)

HIVParityNone1.02
1 child0.7(0.1; 3.6)
2 to 50.6(0.1; 3.0)
more than 54.3(0.7; 26.9)

HSV-2Age at first childNever had1.014
13–183.7(1.1; 12.9)
1948.7(3.0; 792.7)
20–2827.3(3.1; 241.2)
Unknown2.3(0.5; 9.7)

HSV-2Selection of womenAntenatal clinic1.006
Family planning0.1(0.0; 0.8)
Other0(0.0; 0.3)

Trichomona vaginalisHusband's place of residenceManhiça1.002
Maputo2.5(1.0; 6.3)
South Africa1.2(0.6; 2.4)
Unknown0.2(0.1; 0.6)

Trichomona vaginalisAnogenital wartsNo1.018
Yes7.1(1.4; 36.5)

HBsAgNumber of women living with husband11.028
10.1(0.0; 0.8)

Any treatable STI#Anogenital wartsNo1.007
Yes11(1.9; 63.1)

Any active STI##HSV-2 antibodiesNo1.0029
Yes2.4(1.1; 5.4)

Any active STI##Chlamydia trachomatisNo1.042
Yes2.3(1.0; 5.1)

Cervical neoplasiaHPVNo1 .0001
Yes10.1(3.7; 27.5)

Cervical neoplasiaRPRNo1.068
Yes0.2(0.1; 1.1)

*Adjusted by age and ethnic group.
**Likelihood Ratio Test versus model with variable removed.
#Any treatable STI: syphilis (RPR confirmed by IgG), gonococcal infection, trichomona vaginalis or Chlamydia trachomatis.
##Any active STI: syphilis (RPR confirmed by IgG), gonococcal infection, trichomona vaginalis, Chlamydia trachomatis, HPV or HIV infection.